DCRI @ ACC
Stay up to date with the latest news about DCRI and Duke presentations at this year’s Scientific Sessions of the American College of Cardiology.
CV Research at ACC.19
Catch up on the great work presented at ACC.19. Below, the DCRI’s J. Matthew Brennan, MD, and Angela Lowenstern, MD, recap the most exciting research presented in their field and break down clinical implications. View a full playlist of ACC.19 research.
Late-Breaking Clinical Trials
The following late-breaking clinical trials, which were led and supported by the DCRI, were presented during the 2019 ACC Scientific Sessions.
- ADVANCE Registry: Impact of FFRCT on 1-Year Outcomes in Patients Evaluated: Lessons from the ADVANCE Registry
- The Apple Heart Study: Results of a Large-scale, App-based Study to Identify Atrial Fibrillation Using a Smartwatch
- AUGUSTUS Trial: An Open-label, 2 x 2 Factorial, Randomized Trial to Evaluate the Safety of Apixaban versus Vitamin K Antagonist and Aspirin versus Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention: Primary
- PIONEER-HF Trial: Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial
- TREAT: Efficacy of Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction
- WRAP-IT: The World-Wide Randomized Antibiotic Envelope Infection Prevention Trial to Reduce Cardiac Implantable Electronic Device Infection
- ACC 2019: 12-month results show ticagrelor safe in STEMI patients treated with thrombolysis
- ACC 2019: Use of guideline-directed medical therapies for comorbidities may improve outcomes for patients with atrial fibrillation
- ACC 2019: Study confirms diagnostic accuracy of non-invasive technology for heart pain
- ACC 2019: Some heart disease, AF patients on combined therapies could skip aspirin
- ACC 2019: Benefits and drawbacks of high-sensitivity troponin use in low-risk patients with chest pain
- ACC 2019: A multidisciplinary approach to improve care for geriatric heart failure patients
- ACC 2019: Oral anticoagulants underused, aspirin overused to treat atrial fibrillation in patients with advanced chronic kidney disease
- ACC 2019: Disparities persist in treatment of symptomatic aortic valve stenosis
- ACC 2019: Compound improves heart failure biomarker even after hospitalization
- ACC 2019: Heart failure patients not having medication doses increased to recommended targets
Ask the Experts
Sunday, March 17 from 9:30 a.m. to 10:30 a.m.
Patient-Centered, Pragmatic, and Real-World Research
ADAPTABLE Study experts discussed the successes and learned experiences of a patient-centered pragmatic clinical trial at the DCRI booth during ACC19. Team members shared what they have learned about engaging patients as partners, and leveraging electronic health records and claims data to recruit participants and capture primary endpoints.